Pharmacist | Avenova

How to Dispense Avenova®

Why Avenova?

AVENOVA sets a new standard of hygiene care to help manage MGD Dry Eye. Avenova is the only pure hypochlorous acid (HOCl) product shown to safely manage bioburden on the lids and lashes. This is important when managing MGD patients chronically, as Avenova is the only HOCl product FDA cleared for safe, long term use while reducing bacterial load on the lids and lashes, helping keep your patients lids healthy.

icon-microscope

Manages Bacteria Overpopulation1

In a study published in Clinical Ophthalmology, Avenova was shown to reduce the bacterial load significantly without altering the diversity of bacterial species remaining on the skin.

icon-particle

Penetrates Biofilm, killing underlying pathogens2

Avenova has been shown to penetrate biofilm and kill the underlying pathogens.

icon-cells

Inactivates Lipase3

Avenova has been tested to inactivate lipase.

icon-quim-2

In Vitro Comparisons with Betadine4

Avenova has a wider microbial spectrum than Betadine, covering additional bacterial strains.

Questions?

We would love to answer them!

Learn How Avenova can Help!

  1. Stroman, DW. Reduction in bacterial load using hypochlorous acid hygiene solution on ocular skin. Clinical Ophthalmology 2017:11 1-8. Reduction in microbial growth in the solution has not been shown to correlate with a reduction of infections in patients. Clinical studies to evaluate reduction in infection have not been performed.
  2. Romanowski E., Stella N.A., Yates K., Brothers K., Kowalski R.P., Shanks R.M.Q., In Vitro Evaluation of a Hypochlorous Acid Hygiene Solution on Established Biofilms. University of Pittsburgh, 2017
  3. Epstein A, Pang L, Najafi-Tagol K, Najafi R, Stroman DW, Debabov D. Comparison of Bacterial Lipase Activity in the Presence of Eye Lid Cleansers. Presented at ARVO 2013 in Denver, CO.
  4. Klocek, M.S., Mammen, A., Dhaliwal, D., Kowalski, R. Time-Kill Comparison of Povidone Iodine to Hypochlorous Acid against Endophthalmitis Isolates of Staphylococci. ARVO Annual Meeting 2016 Abstract Number 5861